All Any complication No complication p-value
Operative time (min) 586 ± 167 (391-1125) n=34 615.1 ± 121 (400-848) n=14 566.4 ± 194.4 (391-1125) n=20 0.17
EBL (ml) 591.8 ± 611.4 (100-2450) n=33 835.7 ± 810.8 (150-2450) n=14 412.1 ± 330.8 (100-1650) n=19 0.47
Initial HCT (%) 38.2 ± 5.5 (25.1-47.2) n=34 36 ± 5.4 (25.1-43.5) n=14 39.7 ± 5.2 (29-47.2) n=20 0.05
Maximum glucose (mg/dl) during HIPEC phase 140 ± 27.9 (72-187) n=24 146.7 ± 23 (98-187) n=11 134.3 ± 31.2 (72-185) n=13 0.35
Initial CVP (mmHg) 10.9 ± 4.3 (2-19) n=31 12.1 ± 4.5 (2-19) n=14 9.9 ± 4 (4-19) n=17 0.09
End of case CVP (mmHg) 9.9 ± 3.3 (5-18) n=29 10 ± 3.6 (6-18) n=12 9.9 ± 3.1 (5-16) n=17 0.89
Postoperative pH 7.39 ± 0.07 (7.25-7.54 ) n=31 7.40 ± 0.07 (7.30-7.54) n=13 7.38 ± 0.06 (7.25-7.54) n=18 0.66
Intraoperative highest temperature (oC) 38.1 ± 0.9 (35.9-40.1) n=27 38.2 ± 1 (36.4-40.1) n=12 38 ± 0.9 (35.9-39.7) n=15 0.59
Table 3: Analysis of intraoperative variables and their association with postoperative complications. All continuous variables are reported in means + standard deviation, followed by ranges in parenthesis. EBL – estimated blood loss, HCT – hematocrit, CVP – central venous pressure.